AstraZeneca's revenue in Q3 rises 5% to $11.5B - Breaking The News
Download our appPlay StoreApp Store

AstraZeneca's revenue in Q3 rises 5% to $11.5B

EPA-EFE/DAN HIMBRECHTS AUSTRALIA AND NEW ZEALAND OUT

AstraZeneca plc shared on Thursday that in the third quarter of fiscal 2023 its total revenue grew 5% year over year to reach $11.5 billion. On an annual basis, core earnings per share saw a rise of 4%, standing at $1.73, while operating profit surged 58% to $1.9 billion.

In the nine months ending September 30, compared to the same timeframe a year ago, total revenue increased 2% to $33.8 billion, diluted earnings per share skyrocketed 109% to $3.20 and operating profit soared %155 to $6.9 billion.

"Our company continued its strong growth trajectory in the third quarter ... Given the momentum in the year to date we have increased our full-year guidance for Total Revenue excluding COVID medicines as well as for Core EPS," CEO Pascal Soriot said.

Related News
Earnings preview: JPMorgan, TSMC, Wells Fargo and more
The upcoming week promises an action-packed Wednesday, with all eyes on JPMorgan's fourth-quarter results. The company's managed revenue in the third quarter of fiscal 2024 came in at $43.3 billion, rising 6% on an annual basis. Investors will also be looking at BlackRock, Wells Fargo, Goldman Sachs and Citigroup, all of which are slated for Wednesday and will report their fourth-quarter results in a span of a couple of hours. Thursday will start off strong, with...
WEEKLY PREVIEW: Banks' earnings, CPI data and Trump's cabinet
The upcoming week promises to be a busy one for investors as the earnings season gets underway, with major financial institutions like JPMorgan, Goldman Sachs, Morgan Stanley, and Wells Fargo slated to release their reports. Markets will be keenly watching for updates on inflation data from some of the globe's largest economies. Both the United States and the United Kingdom are set to announce their consumer inflation statistics, crucial in understanding...
Walgreens Q1 sales up 7.5% YoY to $39.5B, top expectations
Walgreens Boots Alliance Inc. reported its first quarter results on Friday which saw the company's sales revenue increase 7.5% year-over-year to $39.5 billion, the figure coming above market expectations.As per the report, Walgreens' net loss was at $265 million compared to $67 million in the same period last year, while loss per share in the first quarter clocked in at $0.31 compared to $0.08 a year ago, primarily driven by higher operating losses.The...
Delta posts Q4 revenue of $15.6 billion, up 9%
Delta Air Lines Inc. announced on Friday that its total operating revenue in the fourth quarter of the fiscal year 2024 saw an annual rise of 9% to hit $15.6 billion.The airline's operating income rose by 30% compared to the same trimester in 2023 to land at $1.7 billion. However, the company's net income dipped 59% to reach $843 million. Furthermore, its diluted earnings per share (EPS) nosedived 59% year-on-year to stand at $1.29 per share."2024 was a...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.